InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Koven Andrew I, Director. Director active across 5 companies, notably Kala Pharmaceuticals, Inc.. In total, 9 reports have been recorded. History available since 17 June 2021. The latest transaction was disclosed on 30 June 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Koven Andrew I
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
28,147 shares0Common StockSEC:0001104659-25-064706:0
3,050 shares0Common StockSEC:0001415889-25-017611:0
1,750 shares0Common StockSEC:0001415889-24-016570:0
5,051 shares0Common StockSEC:0001104659-24-069786:0
87,500 shares0Common StockSEC:0001104659-23-084992:0
7,515 shares0Common StockSEC:0001415889-23-010288:0
2,197 sharesCommon StockSEC:0001415889-23-009140:0
25,000 shares0Common StockSEC:0001415889-21-003121:0
1,476,674 sharesCommon SharesSEC:0001104659-16-095183:0
9 of 9 declarations
About Koven Andrew I
KOVEN ANDREW I is Administrateur and has 9 filings in total. The sampled recent filings run from 2016-02-09 to 2025-07-01 and show attribution transactions, with buy and sell amounts of EUR 0 in this sample.
